1 active not recruiting, 1 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Sensorion: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations SENS-501 administration - OTOF Gene Mutation, DFNB9 | Phase 1 / Phase 2 | Active not recruiting | Sensorion | 12 | 2024-06-21 | 2026-07-08 |
| A Study of SENS 401 in Healthy Subjects SENS-401, Placebo - Inner Ear Disease | Phase 1 | Completed | Simbec Research | 36 | 2016-10-21 | 2019-04-08 |
Deafness (1) · Deafness, Autosomal Recessive 9 (1) · Ear Diseases (1) · Hearing Disorders (1) · Hearing Loss (1) · Hearing Loss, Sensorineural (1) · Labyrinth Diseases (1) · Otorhinolaryngologic Diseases (1)
SENS-401 (1)
Australia (1) · France (1) · United Kingdom (1)
2023 (1)